DUSA Financial Facts
NET INCOME (LOSS): -1.42MResearch and development: 1.7M
See Full Income Statement
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY: 41.66M
TOTAL CURRENT LIABILITIES: 5.69M
See Full Balance Sheet
DUSA Pharmaceuticals (DUSA) Earnings
|
Expand Research on DUSA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/12  |
 |
Q212 | $0.06 | $0.06 | $0.00 | $11.7M | $11.85M | N/A |  | | Details |
| 5/8/12 |
|
Q112 | $0.08 | $0.07 | +$0.01 | $13.4M | $12.92M | N/A | | | Details |
| 3/6/12 |
|
Q411 | $0.16 | $0.13 | +$0.03 | $15.3M | $13.84M | N/A | | | Details |
| 11/10/11 |
|
Q311 | $0.05 | $0.00 | +$0.05 | $9.4M | $8.79M | N/A | | | Details |
| 8/2/11 |
|
Q211 | $0.09 | $0.02 | +$0.07 | $9.76M | $10.3M | N/A | | | Details |
| 5/5/11 |
|
Q111 | $0.07 | $0.01 | +$0.06 | $11.1M | $9.79M | N/A | | | Details |
| 3/3/11 |
|
Q410 | $0.12 | $0.04 | +$0.08 | $12M | $10.28M | N/A | | | Details |
